Key result
A 62-year-old male with Kearns-Sayre syndrome experienced a fatal ventricular tachycardia storm that was refractory to antiarrhythmic medications and multiple shocks from his automatic implantable cardioverter defibrillator.
Why the study?
Cardiovascular conduction delay is linked to Kearns-Sayre syndrome, but cases of prolonged QTc, polymorphic ventricular tachycardia, and ineffective AICD use remain poorly understood.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Highlights a severe case of Kearns-Sayre syndrome with prolonged QTc and refractory VT storm leading to mortality despite AICD therapy.
Cardiovascular conduction delay makes up part of the triad associated with Kearns-Sayre syndrome (KSS). Although there have been a few reported cases of prolonged Qtc and polymorphic ventricular tachycardia associated with this disease, despite the use of automatic implantable cardioverter defibrillators (AICD) for secondary prevention, some cases have been reported where the use of AICD did not help. We present a case of a 62-year-old male with KSS who came to the emergency department (ED) after two episodes of syncope. He already had an automatic AICD placed at the age of 34. Our patient had Qtc prolongation which is an unusual finding in KSS. He also had recurrent ventricular tachycardia (VT) refractory to medications and multiple shocks from his AICD, which progressed to a VT storm. He eventually passed away after the withdrawal of care, as his prognosis worsened. We recommend that a more clear guideline will help manage this devastating disease, resulting in mortality reduction.
No takes yet. Share an insight, caveat, or question.
Udongwo et al. (2021) conducted a case report in Kearns-Sayre Syndrome with persistent ventricular tachycardia (n=1). Antiarrhythmic medications and AICD shocks was evaluated on Resolution of ventricular tachycardia storm. A 62-year-old male with Kearns-Sayre syndrome experienced a fatal ventricular tachycardia storm that was refractory to antiarrhythmic medications and multiple shocks from his automatic implantable cardioverter defibrillator.
Synapse has enriched 10 related papers. Consider them for comparative context: